Wild-type mice with matched tumor sizes were injected on days 15 and 20 with MACS-sorted Smad3-WT or Smad3-KO BMDNs, and tumors were assessed on day 25 (Supplementary Fig. 9). The gene discussed is SMAD3; the disease is neoplasm.